{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T09:46:42Z","timestamp":1774950402625,"version":"3.50.1"},"reference-count":13,"publisher":"PAGEPress Publications","issue":"1","license":[{"start":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T00:00:00Z","timestamp":1683504000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Reumatismo"],"abstract":"<jats:p>Cutaneous lupus erythematosus (CLE) is classified into three groups - acute, subacute, and chronic - based on clinical and histopathological characteristics. The risk of systemic manifestations varies among these groups. There are few studies on CLE epidemiology. For this reason, this paper aims to describe CLE prevalence and demographics in Colombia between 2015 and 2019. This descriptive, cross-sectional study used the international classification of diseases, tenth revision, for CLE subtypes, utilizing official data from the Colombian Ministry of Health. In people older than 19 years, 26,356 CLE cases were registered, yielding a prevalence of 76 cases per 100,000 population. CLE was more frequent in females, at a 5:1 ratio compared to males. The most common clinical presentation was discoid lupus erythematosus, in 45% of cases. The majority of cases occurred in people between 55 and 59 years old. This is the first study that describes CLE demographics in adults in Colombia. Findings regarding clinical subtypes and female predominance are consistent with those in the medical literature.<\/jats:p>","DOI":"10.4081\/reumatismo.2023.1568","type":"journal-article","created":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T09:36:32Z","timestamp":1683538592000},"source":"Crossref","is-referenced-by-count":3,"title":["Epidemiology and demographics of cutaneous lupus erythematosus in Colombia between 2015 and 2019"],"prefix":"10.4081","volume":"75","author":[{"given":"D.G.","family":"Fern\u00e1ndez \u00c1vila","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2420-3964","authenticated-orcid":false,"given":"M.","family":"Rivera Maldonado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.P.","family":"Charry Anzola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2549","published-online":{"date-parts":[[2023,5,8]]},"reference":[{"key":"3781","doi-asserted-by":"crossref","unstructured":"Wenzel J. Cutaneous lupus erythematosus: new insights into pathogenesis and therapeutic strategies. Nat Rev Rheumatol. 2019; 15: 519-32.","DOI":"10.1038\/s41584-019-0272-0"},{"key":"3782","doi-asserted-by":"crossref","unstructured":"Blake SC, Daniel BS. Cutaneous lupus erythematosus: a review of the literature. Int J Womens Dermatol. 2019; 5: 320-9.","DOI":"10.1016\/j.ijwd.2019.07.004"},{"key":"3783","doi-asserted-by":"crossref","unstructured":"Ogunsanya M, Kalb S, Kabaria A, Chen S. A systematic review of patient-reported outcomes in patients with cutaneous lupus erythematosus. Br J Dermatol. 2017; 176: 52-61.","DOI":"10.1111\/bjd.14868"},{"key":"3784","doi-asserted-by":"crossref","unstructured":"Koch K, Tikly M. Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus. Lupus. 2019; 28: 1021-6.","DOI":"10.1177\/0961203319856091"},{"key":"3785","doi-asserted-by":"crossref","unstructured":"Jarrett P, Thornley S, Scragg R. Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand. Lupus. 2016; 25: 1497-502.","DOI":"10.1177\/0961203316651745"},{"key":"3786","doi-asserted-by":"crossref","unstructured":"Jarukitsopa S, Hoganson DD, Crowson CS, Sokumbi O, Davis MD, Michet CJ, et al. Epidemiology of systemic lupus erythematosus and cutaneous lupus in a predominantly white population in the United States. Arthritis Care Res. 2015; 67: 817-28.","DOI":"10.1002\/acr.22502"},{"key":"3787","doi-asserted-by":"crossref","unstructured":"Deligny C, Sainte Marie D, Clyti E, Arfi S, Couppie\u0301 P. Pure cutaneous lupus erythematosus in a population of African descent in French Guiana: a retrospective population-based description. Lupus. 2012; 21: 1467-71.","DOI":"10.1177\/0961203312458167"},{"key":"3788","doi-asserted-by":"crossref","unstructured":"De Freitas THP, Proenc\u0327a NG. Chronic cutaneous lupus erythematosus: study of 290 patients [Article in Portuguese]. An Bras Dermatol. 2003; 78: 703-12.","DOI":"10.1590\/S0365-05962003000600005"},{"key":"3789","unstructured":"Ministerio de salud de Colombia. Cifras de aseguramiento en salud. 2021. Available from: https:\/\/www.minsalud.gov.co\/proteccionsocial\/Paginas\/cifras-aseguramiento-salud.aspx."},{"key":"3790","doi-asserted-by":"crossref","unstructured":"Ferna\u0301ndez-A\u0301vila DG, Bernal-Maci\u0301as S, Rinco\u0301n-Rian\u0303o DN, Gutie\u0301rrez Da\u0301vila JM, Rosselli D. Prevalence of systemic lupus erythematosus in Colombia: data from the national health registry 2012-2016. Lupus. 2019; 28: 1273-8.","DOI":"10.1177\/0961203319864168"},{"key":"3791","doi-asserted-by":"crossref","unstructured":"Petersen MP, Mo\u0308ller S, Bygum A, Voss A, Bliddal M. Epidemiology of cutaneous lupus erythematosus and the associated risk of systemic lupus erythematosus: a nationwide cohort study in Denmark. Lupus. 2018; 27: 1424-30.","DOI":"10.1177\/0961203318777103"},{"key":"3792","doi-asserted-by":"crossref","unstructured":"Gro\u0308nhagen CM, Fored CM, Granath F, Nyberg F. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden. Br J Dermatol. 2011; 164: 1335-41.","DOI":"10.1111\/j.1365-2133.2011.10272.x"},{"key":"3793","doi-asserted-by":"crossref","unstructured":"Wallace DJ, Pistiner M, Nessim S, Metzger AL, Klinenberg JR. Cutaneous lupus erythematosus without systemic lupus erythematosus: clinical and laboratory features. Semin Arthritis Rheum. 1992; 21: 221-6.","DOI":"10.1016\/0049-0172(92)90052-F"}],"container-title":["Reumatismo"],"original-title":[],"link":[{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/download\/1568\/969","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/download\/1568\/969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T09:36:45Z","timestamp":1683538605000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.reumatismo.org\/index.php\/reuma\/article\/view\/1568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,8]]},"references-count":13,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,5,8]]}},"URL":"https:\/\/doi.org\/10.4081\/reumatismo.2023.1568","relation":{},"ISSN":["2240-2683","0048-7449"],"issn-type":[{"value":"2240-2683","type":"electronic"},{"value":"0048-7449","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5,8]]}}}